PNOE Will Launch Home Metabolic Testing Device
The company will debut its PNOE 2.0 system on October 1, 2026, to expand access to clinical-grade breath analysis.
Updated on Sept. 27, 2026 in Fitness
Live Poll
Would you rely on data from a wearable breath test to guide your personal fitness routine?
PNOE will release its new PNOE 2.0 device on October 1, 2026, enabling users to perform metabolic testing without a dedicated professional. The self-administered tool captures 23 distinct biomarkers, including VO2 max and resting metabolic rate, during an eight-minute breathing session.
Why it matters
By removing the requirement for trained operators, the company aims to make lab-grade diagnostic technology available in settings beyond traditional hospitals and sports facilities. This shift could democratize access to precise physiological data for athletes and health-conscious consumers.
The PNOE 2.0 device tracks 23 biomarkers, including resting metabolic rate and VO2 max. The test requires eight minutes of breathing into a mask and is not yet cleared by the U.S. Food and Drug Administration.
The players
PNOE
A health technology company headquartered in Malden, Massachusetts, that develops metabolic testing solutions.
Equinox
A luxury fitness club chain that currently utilizes PNOE technology for member services.
NBA
The professional basketball league that serves as a current client for PNOE testing services.
Four Seasons
An international luxury hotel brand that provides PNOE metabolic testing to its guests.
The details
The device features electronics that detach from a silicone mask, allowing individuals to use their own personal mask during the eight-minute testing process. PNOE intends for this system to serve as a bridge toward full clinical diagnostic capabilities, which the company estimates are a couple of years away.
Timeline
PNOE participated in the Y Combinator Winter 2019 batch.
The PNOE 2.0 device is scheduled to launch on October 1, 2026.
The company plans to initiate a Series B funding round between 6 and 12 months after September 2026.
Health Landscape
PNOE operates its new consumer-focused metabolic testing technology outside of the U.S. Food and Drug Administration's medical device clearance process. The development reflects a broader industry movement toward bringing lab-grade physiological insights into non-clinical environments.
The PNOE 2.0 device will allow individuals to monitor their VO2 max and metabolic health without visiting a professional clinic. Consumers should note that the device is currently not cleared by the U.S. Food and Drug Administration, meaning it is intended for health tracking rather than medical diagnosis.
The takeaway
Self-administered health diagnostics are becoming increasingly sophisticated as companies move toward consumer-friendly hardware. Users should carefully distinguish between fitness tracking tools and clinically validated diagnostic devices when managing their personal health.
What happens next
PNOE plans to initiate a Series B funding round within 6 to 12 months of September 2026.
Further reading
Learn more about the latest developments in wellness technology on the Fitness page.
Source note: This article includes information reported by TechCrunch.
Live Poll
Would you rely on data from a wearable breath test to guide your personal fitness routine?
